Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Director departure
Corium International, Inc. (CORI) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/27/2018 8-K Completion of Acquisition or Disposition of Assets, Triggering Events That Accelerate or Increase a Direct Financial Obligati...
Docs: "Amended and Restated Certificate of Incorporation of Corium International, Inc",
"Amended and Restated Bylaws of Corium International, Inc",
"First Supplemental Indenture, between Corium International, Inc. and U.S. Bank National Association"
11/15/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
10/11/2018 8-K Quarterly results
08/09/2018 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "CORIUM INTERNATIONAL, INC. CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS"
05/14/2018 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "CORIUM INTERNATIONAL, INC. CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS"
03/27/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "Presentation materials"
03/20/2018 8-K Submission of Matters to a Vote of Security Holders
03/16/2018 8-K Quarterly results
03/05/2018 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Ob...
Docs: "Indenture, between Corium and U.S. Bank National Association (including the form of 5.00% Convertible Senior Notes due 2025)"
03/01/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"###"
02/08/2018 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "CORIUM INTERNATIONAL, INC. CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Three Months Ended December 31, 2017 2016"
11/16/2017 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "CORIUM INTERNATIONAL, INC. CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS"
08/03/2017 8-K Quarterly results
07/14/2017 8-K Form 8-K - Current report:
05/25/2017 8-K Form 8-K - Current report
05/11/2017 8-K Form 8-K - Current report
05/11/2017 8-K Form 8-K - Current report
05/01/2017 8-K Form 8-K - Current report
03/09/2017 8-K Form 8-K - Current report
02/13/2017 8-K Form 8-K - Current report
02/02/2017 8-K Form 8-K - Current report
01/20/2017 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "†"
01/09/2017 8-K Form 8-K - Current report
11/21/2016 8-K Form 8-K - Current report
08/04/2016 8-K Form 8-K - Current report
06/15/2016 8-K Form 8-K - Current report
05/10/2016 8-K Form 8-K - Current report
03/09/2016 8-K Form 8-K - Current report
02/22/2016 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Corium Announces Positive Topline Results from Phase 1 Clinical Study of Transdermal Corplex™ Memantine as a Potential Treatment of Alzheimer's Disease Demonstrates Pharmacokinetic Profile Supporting the Feasibility of Sustained Transdermal Delivery Webcast and Conference Call Today at 5:00 p.m. ET",
"Presentation materials for conference call on February 22, 2016"
02/12/2016 8-K Entry into a Material Definitive Agreement
02/08/2016 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "CORIUM INTERNATIONAL, INC. CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS"
02/03/2016 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Corium Announces Positive Topline Results from Phase 1 PK Clinical Study of Once-weekly Transdermal Corplex™ Donepezil as a Potential Treatment of Alzheimer's Disease Demonstrates Sustained Delivery, Acceptable Skin Tolerability, and Pharmacokinetic Profile to Support the Feasibility of Once-weekly Dosing Webcast and Conference Call Today at 5:00 p.m. ET",
"Presentation materials for conference call on February 3, 2016"
12/30/2015 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Controlled Equity Offering Sales Agreement",
"Opinion of Fenwick & West LLP"
11/12/2015 8-K Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Corium Reports Fourth Quarter and Fiscal Year 2015 Financial Results and Year-End Highlights"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy